Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from 4DMedical Ltd ( (AU:4DX) ) is now available.
4DMedical Ltd has applied for quotation on the ASX of 1,583,776 new fully paid ordinary shares issued on 26 February 2026, following the exercise or conversion of existing options or other convertible securities. The additional shares will increase the company’s quoted capital base, modestly enhancing liquidity in its stock and signalling ongoing utilisation of equity-linked incentives by investors or employees.
The application confirms 4DMedical’s continued engagement with capital markets as it advances its medical imaging technologies for respiratory healthcare. While the issuance is relatively small in scale, it reflects incremental funding and ownership consolidation that may support the company’s operational and growth initiatives within the medtech sector.
The most recent analyst rating on (AU:4DX) stock is a Hold with a A$4.00 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Ltd, listed on the ASX under the ticker 4DX, operates in the medical technology sector, focusing on advanced imaging solutions for respiratory and pulmonary health. The company develops and commercialises diagnostic technologies designed to improve the analysis of lung function, targeting healthcare providers and institutions treating respiratory conditions.
Average Trading Volume: 6,896,428
Technical Sentiment Signal: Buy
Current Market Cap: A$2.41B
Find detailed analytics on 4DX stock on TipRanks’ Stock Analysis page.